Add Company
Join Now

Polyneuron Pharmaceuticals AG Revenue and Competitors

License our Company Data API

Basel,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Polyneuron Pharmaceuticals AG's estimated annual revenue is currently $1.2M per year.(i)
  • Polyneuron Pharmaceuticals AG's estimated revenue per employee is $201,000

Employee Data

  • Polyneuron Pharmaceuticals AG has 6 Employees.(i)
  • Polyneuron Pharmaceuticals AG grew their employee count by -74% last year.

Polyneuron Pharmaceuticals AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.7M26716%N/AN/A
#2
$53.1M26421%N/AN/A
#3
$69.1M34426%N/AN/A
#4
$22.1M110-10%N/AN/A
#5
$151.8M75511%N/AN/A
#6
$63.9M31813%N/AN/A
#7
$29.9M14913%N/AN/A
#8
$1.7M17-6%$114.3MN/A
#9
$6.8M34-6%N/AN/A
#10
$12.5M62-9%N/AN/A
Add Company

What Is Polyneuron Pharmaceuticals AG?

Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-Catchâ„¢ technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$1.2M

Revenue (est)

-74%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Polyneuron Pharmaceuticals AG News

2022-02-22 - Polyneuron and University of Basel Awarded Grant of CHF 1.2M to ...

BASEL, Switzerland--(BUSINESS WIRE)--Polyneuron Pharmaceuticals AG, a clinical-stage developer of a new class of antigen-specific polymers...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M650%N/A
#2
$1.4M7-53%N/A
#3
$0.6M80%N/A
#4
$0.6M8N/AN/A
#5
$1.1M9-10%N/A